Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 342

1.

Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.

Roberts DM, Roberts JA, Roberts MS, Liu X, Nair P, Cole L, Lipman J, Bellomo R; RENAL Replacement Therapy Study Investigators.

Crit Care Med. 2012 May;40(5):1523-8. doi: 10.1097/CCM.0b013e318241e553.

PMID:
22511133
[PubMed - indexed for MEDLINE]
2.

The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.

Jamal JA, Udy AA, Lipman J, Roberts JA.

Crit Care Med. 2014 Jul;42(7):1640-50. doi: 10.1097/CCM.0000000000000317.

PMID:
24674926
[PubMed - indexed for MEDLINE]
3.

Pharmacokinetics and pharmacodynamics of piperacillin-tazobactam in 42 patients treated with concomitant CRRT.

Bauer SR, Salem C, Connor MJ Jr, Groszek J, Taylor ME, Wei P, Tolwani AJ, Fissell WH.

Clin J Am Soc Nephrol. 2012 Mar;7(3):452-7. doi: 10.2215/CJN.10741011. Epub 2012 Jan 26.

PMID:
22282479
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?

Roberts JA, Roberts MS, Robertson TA, Dalley AJ, Lipman J.

Crit Care Med. 2009 Mar;37(3):926-33. doi: 10.1097/CCM.0b013e3181968e44.

PMID:
19237898
[PubMed - indexed for MEDLINE]
5.

Alveolar concentrations of piperacillin/tazobactam administered in continuous infusion to patients with ventilator-associated pneumonia.

Boselli E, Breilh D, Rimmelé T, Guillaume C, Xuereb F, Saux MC, Bouvet L, Chassard D, Allaouchiche B.

Crit Care Med. 2008 May;36(5):1500-6. doi: 10.1097/CCM.0b013e318170ba21.

PMID:
18434883
[PubMed - indexed for MEDLINE]
6.

Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysis.

Asín-Prieto E, Rodríguez-Gascón A, Trocóniz IF, Soraluce A, Maynar J, Sánchez-Izquierdo JÁ, Isla A.

J Antimicrob Chemother. 2014 Jan;69(1):180-9. doi: 10.1093/jac/dkt304. Epub 2013 Aug 1.

PMID:
23908259
[PubMed - indexed for MEDLINE]
7.

Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.

Boereboom FT, Ververs FF, Blankestijn PJ, Savelkoul TJ, van Dijk A.

Intensive Care Med. 1999 Oct;25(10):1100-4.

PMID:
10551965
[PubMed - indexed for MEDLINE]
8.

Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis.

Connor MJ Jr, Salem C, Bauer SR, Hofmann CL, Groszek J, Butler R, Rehm SJ, Fissell WH.

Antimicrob Agents Chemother. 2011 Feb;55(2):557-60. doi: 10.1128/AAC.00548-10. Epub 2010 Nov 29.

PMID:
21115798
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Case-control study of drug monitoring of β-lactams in obese critically ill patients.

Hites M, Taccone FS, Wolff F, Cotton F, Beumier M, De Backer D, Roisin S, Lorent S, Surin R, Seyler L, Vincent JL, Jacobs F.

Antimicrob Agents Chemother. 2013 Feb;57(2):708-15. doi: 10.1128/AAC.01083-12. Epub 2012 Nov 12.

PMID:
23147743
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.

Tegeder I, Neumann F, Bremer F, Brune K, Lötsch J, Geisslinger G.

Clin Pharmacol Ther. 1999 Jan;65(1):50-7.

PMID:
9951430
[PubMed - indexed for MEDLINE]
11.

Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.

Giles LJ, Jennings AC, Thomson AH, Creed G, Beale RJ, McLuckie A.

Crit Care Med. 2000 Mar;28(3):632-7.

PMID:
10752806
[PubMed - indexed for MEDLINE]
12.

Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration.

Ververs TF, van Dijk A, Vinks SA, Blankestijn PJ, Savelkoul JF, Meulenbelt J, Boereboom FT.

Crit Care Med. 2000 Oct;28(10):3412-6.

PMID:
11057794
[PubMed - indexed for MEDLINE]
13.

Population pharmacokinetics of piperacillin/tazobactam in critically ill young children.

Cies JJ, Shankar V, Schlichting C, Kuti JL.

Pediatr Infect Dis J. 2014 Feb;33(2):168-73. doi: 10.1097/INF.0b013e3182a743c7.

PMID:
23907263
[PubMed - indexed for MEDLINE]
14.

Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.

Taccone FS, Laterre PF, Dugernier T, Spapen H, Delattre I, Wittebole X, De Backer D, Layeux B, Wallemacq P, Vincent JL, Jacobs F.

Crit Care. 2010;14(4):R126. doi: 10.1186/cc9091. Epub 2010 Jul 1.

PMID:
20594297
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Pharmacokinetic analysis of piperacillin administered with tazobactam in critically ill, morbidly obese surgical patients.

Sturm AW, Allen N, Rafferty KD, Fish DN, Toschlog E, Newell M, Waibel B.

Pharmacotherapy. 2014 Jan;34(1):28-35. doi: 10.1002/phar.1324. Epub 2013 Jul 17.

PMID:
23864417
[PubMed - indexed for MEDLINE]
16.

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis.

Roberts JA, Kirkpatrick CM, Roberts MS, Dalley AJ, Lipman J.

Int J Antimicrob Agents. 2010 Feb;35(2):156-63. doi: 10.1016/j.ijantimicag.2009.10.008. Epub 2009 Dec 16.

PMID:
20018492
[PubMed - indexed for MEDLINE]
17.

Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis.

Kielstein JT, Czock D, Schöpke T, Hafer C, Bode-Böger SM, Kuse E, Keller F, Fliser D.

Crit Care Med. 2006 Jan;34(1):51-6.

PMID:
16374156
[PubMed - indexed for MEDLINE]
18.

Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy.

Trotman RL, Williamson JC, Shoemaker DM, Salzer WL.

Clin Infect Dis. 2005 Oct 15;41(8):1159-66. Epub 2005 Sep 12. Review.

PMID:
16163635
[PubMed - indexed for MEDLINE]
Free Article
19.

Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drains.

Adnan S, Li JX, Wallis SC, Rudd M, Jarrett P, Paterson DL, Lipman J, Udy AA, Roberts JA.

Int J Antimicrob Agents. 2013 Jul;42(1):90-3. doi: 10.1016/j.ijantimicag.2013.02.023. Epub 2013 Apr 13.

PMID:
23590897
[PubMed - indexed for MEDLINE]
20.

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.

Roberts JA, Kirkpatrick CM, Roberts MS, Robertson TA, Dalley AJ, Lipman J.

J Antimicrob Chemother. 2009 Jul;64(1):142-50. doi: 10.1093/jac/dkp139. Epub 2009 Apr 27.

PMID:
19398460
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk